BIOTECH Logo

BIOTECH

Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Biat Group is a biotechnology corporate group that operates a global commercial network under its holding company, Bionatur. The group consists of several subsidiaries with distinct specializations. Biobide is a worldwide leader in providing tailor-made toxicity and efficacy preclinical testing using the zebrafish (ZF) animal model. ZIP Solutions develops and commercializes a unique proprietary set of intein technologies for high-value applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines, and protein purification. The group also holds biotech assets for human and animal health through Bionatur. Key areas for future collaboration include licensing of its platforms, preclinical research services, and the improvement of recombinant and DNA vaccines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom CAU
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan 3696
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea 085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea 351870
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea 030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan 4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A

Talk to a Data Expert

Have a question? We'll get back to you promptly.